首页> 外文期刊>BMJ Open >Compensatory changes in energy balance during dapagliflozin treatment in type 2 diabetes mellitus: a randomised double-blind, placebo-controlled, cross-over trial (ENERGIZE)?¢??study protocol
【24h】

Compensatory changes in energy balance during dapagliflozin treatment in type 2 diabetes mellitus: a randomised double-blind, placebo-controlled, cross-over trial (ENERGIZE)?¢??study protocol

机译:达格列净治疗2型糖尿病期间能量平衡的补偿性变化:一项随机双盲,安慰剂对照,交叉试验(ENERGIZE)的研究方案

获取原文
           

摘要

Abstract Introduction Sodium glucose cotransporter 2 (SGLT2) inhibitors are effective blood-glucose-lowering medications with beneficial effects on body weight in patients with type 2 diabetes mellitus (T2DM). However, observed weight loss is less than th
机译:摘要简介葡萄糖共转运蛋白2(SGLT2)抑制剂是有效的降血糖药物,对2型糖尿病(T2DM)患者的体重具有有益作用。但是,观察到的体重减轻小于

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号